{{Rsnum
|rsid=11220082
|Gene=FEZ1
|Chromosome=11
|position=125454069
|Orientation=plus
|GMAF=0.4706
|Gene_s=FEZ1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 13.3 | 54.9 | 31.9
| HCB | 9.5 | 48.9 | 41.6
| JPT | 16.8 | 57.5 | 25.7
| YRI | 49.7 | 42.2 | 8.2
| ASW | 40.4 | 52.6 | 7.0
| CHB | 9.5 | 48.9 | 41.6
| CHD | 12.0 | 47.2 | 40.7
| GIH | 11.9 | 36.6 | 51.5
| LWK | 57.3 | 39.1 | 3.6
| MEX | 35.1 | 43.9 | 21.1
| MKK | 47.4 | 44.9 | 7.7
| TSI | 33.3 | 48.0 | 18.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22688191
|Trait=None
|Title=Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
|RiskAllele=
|Pval=7E-7
|OR=1.1000
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}